Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Manar Al-Ghabeish, Ph.D.
US Food and Drug Administration
Poster(s):
(M1230-05-30) Application of Quantitative Models to Systematically Evaluate Factors Impacting Swallowability of Tablets
Monday, October 23, 2023
12:30 PM – 1:30 PM
ET
(T1530-08-54) Critical Formulation Attributes of Naloxone Nasal Spray Products Affecting Nasal Permeation
Tuesday, October 24, 2023
3:30 PM – 4:30 PM
ET
(T1030-10-66) Identifying Critical Parameters for Physiological Based Pharmacokinetic Modeling of Naloxone Hydrochloride Nasal Sprays
Tuesday, October 24, 2023
10:30 AM – 11:30 AM
ET
